HomeOCEAW • NASDAQ
add
Ocean Biomedical
Previous close
$0.040
Day range
$0.036 - $0.039
Year range
$0.019 - $0.68
Market cap
35.00M USD
Avg Volume
41.92K
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.66M | -16.33% |
Net income | -14.09M | -284.05% |
Net profit margin | — | — |
Earnings per share | -0.52 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 31.00K | -73.28% |
Total assets | 1.03M | -9.08% |
Total liabilities | 76.26M | 595.12% |
Total equity | -75.22M | — |
Shares outstanding | 34.65M | — |
Price to book | -0.02 | — |
Return on assets | -415.88% | — |
Return on capital | 12.88% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -14.09M | -284.05% |
Cash from operations | -1.13M | -155.66% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.13M | -303.57% |
Free cash flow | -833.50K | — |
About
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Founded
2019
Headquarters
Website
Employees
9